GHITM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.671000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.455000E-01
Normal-vs-Stage2
9.511600E-01
Normal-vs-Stage3
2.729600E-01
Normal-vs-Stage4
9.603800E-01
Stage1-vs-Stage2
1.950220E-01
Stage1-vs-Stage3
1.535230E-01
Stage1-vs-Stage4
5.247600E-01
Stage2-vs-Stage3
2.127800E-01
Stage2-vs-Stage4
9.930600E-01
Stage3-vs-Stage4
4.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.286800E-01
Normal-vs-AfricanAmerican
4.511200E-01
Normal-vs-Asian
9.999400E-01
Caucasian-vs-AfricanAmerican
2.128600E-01
Caucasian-vs-Asian
8.686600E-01
AfricanAmerican-vs-Asian
3.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.085800E-01
Normal-vs-Female
9.556800E-01
Male-vs-Female
5.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.438200E-01
Normal-vs-Age(41-60Yrs)
6.048600E-01
Normal-vs-Age(61-80Yrs)
7.496000E-01
Normal-vs-Age(81-100Yrs)
9.621000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.995610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.357800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.809200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.420200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.702400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.419000E-01
Normal-vs-Daily Drinker
9.425200E-01
Normal-vs-Weekly Drinker
5.326600E-01
Normal-vs-Occasional Drinker
6.219800E-01
Normal-vs-Social Drinker
7.579400E-01
Non Drinker-vs-Daily Drinker
4.543000E-01
Non Drinker-vs-Weekly Drinker
7.954200E-01
Non Drinker-vs-Occasional Drinker
5.871600E-02
Non Drinker-vs-Social Drinker
1.474360E-01
Daily Drinker-vs-Weekly Drinker
4.031200E-01
Daily Drinker-vs-Occasional Drinker
3.036200E-01
Daily Drinker-vs-Social Drinker
4.895400E-01
Weekly Drinker-vs-Occasional Drinker
6.910200E-02
Weekly Drinker-vs-Social Drinker
1.549960E-01
Occasional Drinker-vs-Social Drinker
8.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.100760E-01
Normal-vs-Grade 2
3.752400E-02
Normal-vs-Grade 3
2.574300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.514400E-01
Grade 1-vs-Grade 3
4.116400E-01
Grade 1-vs-Grade 4
1.100760E-01
Grade 2-vs-Grade 3
7.028600E-01
Grade 2-vs-Grade 4
3.752400E-02
Grade 3-vs-Grade 4
2.574300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.538400E-01
Normal-vs-NonDiabetic
8.833800E-01
Diabetic-vs-NonDiabetic
8.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.234000E-01
Normal-vs-NoPancreatitis
8.823200E-01
Pancreatitis-vs-NoPancreatitis
3.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.191800E-01
Normal-vs-N1
9.347600E-01
N0-vs-N1
5.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.583000E-01
Normal-vs-TP53-NonMutant
9.827600E-01
TP53-Mutant-vs-TP53-NonMutant
3.016400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
